{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T16:47:19Z","timestamp":1776790039577,"version":"3.51.2"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,9]],"date-time":"2018-11-09T00:00:00Z","timestamp":1541721600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000664","name":"Health Technology Assessment Programme","doi-asserted-by":"publisher","award":["13\/88\/21"],"award-info":[{"award-number":["13\/88\/21"]}],"id":[{"id":"10.13039\/501100000664","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13063-018-2998-4","type":"journal-article","created":{"date-parts":[[2018,11,9]],"date-time":"2018-11-09T13:14:56Z","timestamp":1541769296000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["ALternatives To prophylactic Antibiotics for the treatment of Recurrent urinary tract infection in women (ALTAR): study protocol for a multicentre, pragmatic, patient-randomised, non-inferiority trial"],"prefix":"10.1186","volume":"19","author":[{"given":"Rebecca","family":"Forbes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ased","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alaa","family":"Abouhajar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Brennand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonya","family":"Carnell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Chadwick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian","family":"Eardley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Lecouturier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"Mossop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian","family":"Pearce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Pickard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikesh","family":"Thiruchelvam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine","family":"Walton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Wilkinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9407-382X","authenticated-orcid":false,"given":"Chris","family":"Harding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,11,9]]},"reference":[{"key":"2998_CR1","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1007\/s15010-007-6180-2","volume":"35","author":"KB Laupland","year":"2007","unstructured":"Laupland KB, Ross T, Pitout JD, et al. Community-onset urinary tract infections: a population based assessment. Infection. 2007;35:150\u20133.","journal-title":"Infection"},{"key":"2998_CR2","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1093\/clinids\/22.1.91","volume":"22","author":"R Ikaheimo","year":"1996","unstructured":"Ikaheimo R, Sutonen A, Heiskanen T, Karkkainen U, Kuosmanen P, et al. Recurrence of urinary tract infection in a primary care setting: analysis of a 1-year follow-up of 179 women. Clin Infect Dis. 1996;22:91\u20139.","journal-title":"Clin Infect Dis"},{"key":"2998_CR3","unstructured":"2011 Census. Population Estimates for the United Kingdom: Office for National Statistics; 2011. Retrieved September 2013 https:\/\/www.ons.gov.uk\/peoplepopulationandcommunity\/populationandmigration\/populationestimates\/bulletins\/2011censuspopulationestimatesfortheunitedkingdom\/2012-12-17 ."},{"key":"2998_CR4","doi-asserted-by":"publisher","unstructured":"Albert X, Huertas I, Pereiro I, Sanf\u00e9lix J, Gosalbes V, Perrotta C. Antibiotics for preventing recurrent urinary tract infection in non-pregnant women. Cochrane Database Syst Rev 2004, Issue 3. Art. No.: CD001209. doi: https:\/\/doi.org\/10.1002\/14651858.CD001209.pub2 .","DOI":"10.1002\/14651858.CD001209.pub2"},{"key":"2998_CR5","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1001\/archinternmed.2012.777","volume":"172","author":"MA Beerepoot","year":"2012","unstructured":"Beerepoot MA, Ter Riet G, Nys S, van der Wal WM, de Borgie CA, et al. Lactobacilli vs antibiotics to prevent urinary tract infections: a randomized, double-blind, non-inferiority trial in postmenopausal women. Arch Intern Med. 2012;172:704\u201312.","journal-title":"Arch Intern Med"},{"key":"2998_CR6","volume-title":"UK antimicrobial resistance strategy and action plan","author":"Department of Health","year":"2000","unstructured":"Department of Health. UK antimicrobial resistance strategy and action plan. London: Department of Health; 2000."},{"key":"2998_CR7","unstructured":"Healthcare Associated Infection Task Force. The Scottish management of antimicrobial resistance action plan [ScotMARAP] 2008. Edinburgh: Scottish Government. p. 2008."},{"key":"2998_CR8","unstructured":"Scottish Intercollegiate Guidelines Network (SIGN). Management of suspected bacterial urinary tract infection in adults. Edinburgh: SIGN; 2012. (SIGN publication no. 88). [July 2012]. Available from URL: http:\/\/www.sign.ac.uk . Accessed 1 Nov 2018."},{"key":"2998_CR9","unstructured":"Urological Infections. 2013 European Association of Urology Guidelines. ISBN 978-90-79754-71-7."},{"key":"2998_CR10","doi-asserted-by":"publisher","unstructured":"Lee BSB, Bhuta T, Simpson JM, Craig JC. Methenamine hippurate for preventing urinary tract infections. Cochrane Database Syst Rev 2012, Issue 10. Art. No.: CD003265. doi: https:\/\/doi.org\/10.1002\/14651858.CD003265.pub3","DOI":"10.1002\/14651858.CD003265.pub3"},{"issue":"3","key":"2998_CR11","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1056\/NEJM198201213060302","volume":"306","author":"BE Murray","year":"1982","unstructured":"Murray BE, Rensimer ER, DuPont HL. Emergence of high-level trimethoprim resistance in fecal Escherichia coli during oral administration of trimethoprim or trimethoprim\u2013sulfamethoxazole. N Engl J Med. 1982;306(3):130\u20135.","journal-title":"N Engl J Med"},{"issue":"1","key":"2998_CR12","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1093\/jac\/dkg280","volume":"52","author":"G Kahlmeter","year":"2003","unstructured":"Kahlmeter G, Menday P. Cross-resistance and associated resistance in 2478 Escherichia coli isolates from the Pan-European ECO.SENS Project surveying the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections. J Antimicrob Chemother. 2003;52(1):128\u201331.","journal-title":"J Antimicrob Chemother"},{"key":"2998_CR13","unstructured":"UK antmicrobial resistance strategy. Department of Health. London; 2013. www.gov.uk\/dh . Accessed 5 Oct 2018."},{"issue":"5","key":"2998_CR14","doi-asserted-by":"publisher","first-page":"e103","DOI":"10.1093\/cid\/ciq257","volume":"52","author":"K Gupta","year":"2011","unstructured":"Gupta K, Hooton TM, Naber KG, Infectious Diseases Society of America; European Society for Microbiology and Infectious Diseases, et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin InfectDis. 2011;52(5):e103\u201320.","journal-title":"Clin InfectDis"},{"issue":"9","key":"2998_CR15","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/S1473-3099(10)70143-2","volume":"10","author":"KK Kumarasamy","year":"2010","unstructured":"Kumarasamy KK, Toleman MA, Walsh TR, et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis. 2010;10(9):597\u2013602.","journal-title":"Lancet Infect Dis"},{"key":"2998_CR16","volume-title":"Good practice recommendations for hospital antimicrobial stewardship in NHS Scotland","author":"Scottish Medicines Consortium","year":"2012","unstructured":"Scottish Medicines Consortium, Scottish Antimicrobial Prescribing Group. Good practice recommendations for hospital antimicrobial stewardship in NHS Scotland. Glasgow: SMC; 2012."},{"key":"2998_CR17","volume-title":"Quarterly report on the surveillance of Clostridium difficile infection (CDI) in Scotland, October\u2013December 2011","author":"Health Protection Scotland","year":"2012","unstructured":"Health Protection Scotland. Quarterly report on the surveillance of Clostridium difficile infection (CDI) in Scotland, October\u2013December 2011. Glasgow: HPS; 2012."},{"key":"2998_CR18","first-page":"1981","volume":"109","author":"B MAJ","year":"2013","unstructured":"MAJ B, Geerlings SE, van Haarst EP, Mensing van Charante N, Riet G. Nonantibiotic prophylaxis for recurrent urinary tract infections: a systematic review and meta-analysis of randomized controlled trials. J Urol. 2013;109:1981.","journal-title":"J Urol"},{"key":"2998_CR19","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1477-7525-2-12","volume":"2","author":"MJ Atkinson","year":"2004","unstructured":"Atkinson MJ, Sinha A, Hass SL, Colman SS, Kumar RN, Brod M, et al. Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic disease. Health Qual Life Outcomes 2004;2:12.","journal-title":"Health Qual Life Outcomes"},{"key":"2998_CR20","volume-title":"Unit costs of health and social care","author":"L Curtis","year":"2007","unstructured":"Curtis L. Unit costs of health and social care. Canterbury: PSSRU, University of Kent; 2007."},{"key":"2998_CR21","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780198529446.001.0001","volume-title":"Methods for the economic evaluation of health care programmes","author":"M Drummond","year":"2005","unstructured":"Drummond M, Sculpher M, Torrance G, O'Brien B, Stoddart G. Methods for the economic evaluation of health care programmes. 3rd ed. New York: Oxford University press; 2005.","edition":"3"},{"issue":"36","key":"2998_CR22","doi-asserted-by":"publisher","first-page":"iii","DOI":"10.3310\/hta8360","volume":"8","author":"Z Philips","year":"2004","unstructured":"Philips Z, Ginnelly L, Sculpher M, Claxton K, Golder S, Riemsma R, et al. Review of guidelines for good practice in decision-analytic modelling in health technology assessment. Health Technol Assess. 2004;8(36):iii -iv, ix-xi, 1-158.","journal-title":"Health Technol Assess"},{"key":"2998_CR23","unstructured":"Guide to the methods of technology appraisal. London: National Institute for Health and Clinical Excellence, 2008; [accessed July 2015]. URL: https:\/\/www.nice.org.uk\/process\/pmg9\/chapter\/foreword ."},{"key":"2998_CR24","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.jval.2012.06.012","volume":"15","author":"JJ Caro","year":"2012","unstructured":"Caro JJ, Briggs AH, Siebert U, et al. Modelling good research practices\u2014overview: a report of the ISPOR-SMDM modeling good research practices task force-1. Value Health. 2012;15:796\u2013803.","journal-title":"Value Health"},{"issue":"1","key":"2998_CR25","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/hec.3564","volume":"27","author":"N Devlin","year":"2018","unstructured":"Devlin N, Shah K, Feng Y, Mulhern B, van Hout B. Valuing health-related quality of life: an EQ-5D-5L value set for England. Health Econ. 2018;27(1):7\u201322.","journal-title":"Health Econ"},{"key":"2998_CR26","unstructured":"Public Health England. UK Standards for Microbiology Investigations (UK SMI) B 41: Investigation of Urine. 2018. URL: https:\/\/www.gov.uk\/government\/publications\/smi-b-41-investigation-of-urine . Accessed 5 Oct 2018."},{"key":"2998_CR27","volume-title":"Breakpoint tables for interpretation of MICs and zone diameters, version 7.1","author":"The European Committee on Antimicrobial Susceptibility Testing","year":"2017","unstructured":"The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters, version 7.1. 2017. URL: http:\/\/www.eucast.org\/clinical_breakpoints\/ (Accessed 10\/05\/2018)."}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-018-2998-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13063-018-2998-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-018-2998-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T06:41:56Z","timestamp":1720766516000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-018-2998-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,9]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["2998"],"URL":"https:\/\/doi.org\/10.1186\/s13063-018-2998-4","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,9]]},"assertion":[{"value":"6 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The conduct of this trial will be in accordance with the recommendations for physicians involved in research on human subjects adopted by the 18th World Medical Assembly, Helsinki 1964 and later revisions. Favourable ethical opinion (REF: 15\/NE\/0381) from NRES Committee North East \u2013 Tyne and Wear South and Clinical Trial Authorisation (MHRA Ref:17136\/0279\/001\u20130001) from relevant competent authorities (CAs) was sought prior to commencement of the trial. Local approvals will be sought before recruitment commences. All amendments to the protocol and supporting documents will be submitted to the Research Ethics Committee and\/or relevant CAs where necessary for approval. Copies of these approvals (original and all amendments) will be kept in the Trial Master File (TMF) at NCTU and in the ISF at local sites.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"616"}}